Key result
PCI with adequate clotting factors succeeds in a 70-year-old man with haemophilia B and NSTEMI.
Why the study?
Patients with haemophilia and acute coronary syndrome are susceptible to periprocedural bleeding and thrombotic events during PCI, presenting a management challenge.
Case Report (n=1)
No
Highlights the necessity of a multidisciplinary approach, including clotting factor administration, to balance bleeding and thrombotic risks when performing PCI in patients with haemophilia and ACS.
Case report suggests PCI feasibility with factor support in haemophilia B and NSTEMI; leaves open optimal protocols and generalizability.
We present the case of a 70-year-old man with a history of haemophilia B, who presented to our hospital with a non-ST-elevation myocardial infarction. The patient, following consultation by a haemophilia expert, was revascularized with percutaneous coronary intervention (PCI) under adequate clotting factor administration. Patients with haemophilia and acute coronary syndrome, are susceptible to periprocedural bleeding and thrombotic events during PCI, and therefore a balanced management plan should always be implemented by a multidisciplinary team.
No takes yet. Share an insight, caveat, or question.
Theodoropoulos et al. (2021) conducted a case report in Haemophilia B and non-ST-elevation myocardial infarction (n=1). Percutaneous coronary intervention (PCI) with clotting factor administration was evaluated. Percutaneous coronary intervention with adequate clotting factor administration was successfully performed in a 70-year-old man with haemophilia B and NSTEMI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: